Redmile Group, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Zymeworks Inc. (ZYME)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Zymeworks Inc. Common Stock, par value $0.00001 per share
Symbol
ZYME
Shares outstanding
69.1M shares
Disclosed Ownership
4.84M shares
Ownership
7%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 08:04 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 7% 4.84M 0 4.84M /s/ Jeremy C. Green Managing Member
Jeremy C. Green 7% 4.84M 0 4.84M /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 5% 3.47M 0 3.47M /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.